It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine
Author
Zhou Xingdong 1 ; Wang, Hui 2 ; Ji Qun 3 ; Du Mingjuan 3 ; Liang Yuexia 4 ; Li Huanhuan 4 ; Li, Fan 4 ; Shang Hang 4 ; Zhu, Xiujuan 2 ; Wang, Wei 3 ; Jiang Lichun 3 ; Stepanov, Alexey V 5 ; Ma Tianyu 4 ; Gong Nanxin 4 ; Jia Xiaodong 6 ; Gabibov, Alexander G 5 ; Lou Zhiyong 7 ; Lu Yinying 6 ; Guo, Yu 4 ; Zhang, Hongkai 1 ; Yang, Xiaoming 2
1 Nankai University, State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Tianjin, China (GRID:grid.216938.7) (ISNI:0000 0000 9878 7032); ShanghaiTech University, Shanghai Institute for Advanced Immunochemical Studies, Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879)
2 Beijing Institute of Biological Products Company Limited, Beijing, China (GRID:grid.419781.2) (ISNI:0000 0004 0388 5844)
3 ShanghaiTech University, Shanghai Institute for Advanced Immunochemical Studies, Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879)
4 Nankai University, State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Tianjin, China (GRID:grid.216938.7) (ISNI:0000 0000 9878 7032)
5 M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia (GRID:grid.4886.2) (ISNI:0000 0001 2192 9124)
6 The 5th Medical Center of PLA General Hospital, Comprehensive Liver Cancer Center, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894)
7 Tsinghua University, MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178)
1 Nankai University, State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Tianjin, China (GRID:grid.216938.7) (ISNI:0000 0000 9878 7032); ShanghaiTech University, Shanghai Institute for Advanced Immunochemical Studies, Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879)
2 Beijing Institute of Biological Products Company Limited, Beijing, China (GRID:grid.419781.2) (ISNI:0000 0004 0388 5844)
3 ShanghaiTech University, Shanghai Institute for Advanced Immunochemical Studies, Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879)
4 Nankai University, State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Tianjin, China (GRID:grid.216938.7) (ISNI:0000 0000 9878 7032)
5 M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia (GRID:grid.4886.2) (ISNI:0000 0001 2192 9124)
6 The 5th Medical Center of PLA General Hospital, Comprehensive Liver Cancer Center, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894)
7 Tsinghua University, MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178)
Pages
818-823
Publication year
2021
Publication date
Oct 2021
ISSN
1674800X
e-ISSN
16748018
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2576462301
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.